Supriya Lifescience names Dr. Saloni Wagh as MD
People

Supriya Lifescience names Dr. Saloni Wagh as MD

Shivani Satish Wagh takes on the role of Joint Managing Director

  • By IPP Bureau | August 03, 2024

Supriya Lifescience Ltd., a global leader in the manufacturing of Active Pharmaceutical Ingredients (APIs), is embarking on an exciting new chapter with a major leadership reshuffle.

The company has announced the appointment of the Wagh family's next generation to key leadership positions. Dr. Saloni Wagh takes over as Managing Director, offering a fresh and innovative viewpoint. Shivani Satish Wagh takes on the role of Joint Managing Director, ready to drive strategic growth. Meanwhile, Dr. Satish Waman Wagh takes on the role of Whole-Time Director and Executive Chairman, combining considerable experience with imaginative leadership. This strategic shift demonstrates Supriya Life science’s dedication to moving forward with new enthusiasm and quality.

Dr. Saloni Wagh holds a master’s degree in science from the University of Mumbai and a Ph.D. in Chemistry from the Faculty of Science, Pacific University, Udaipur, India. With over 10 years of experience in business operations and marketing, Dr. Saloni has played an integral role in Supriya Lifescience’s success and growth, particularly in terms of revenue. Her dynamic leadership and strategic vision have been pivotal in propelling Supriya Lifescience to new heights.

Shivani Wagh joined Supriya Lifescience Ltd. in 2014, bringing with her an impressive educational background and a lot of experience. Shivani specializes in marketing and global commerce, having earned a Bachelor of Management Studies from Mumbai University and dual master’s degrees in commerce and international business management from the University of Manchester, UK. Her strategic thoughts and thorough awareness of the pharmaceutical landscape have been critical in improving organizational success.

Dr. Satish Wagh, Founder of Supriya Lifescience Ltd., has been appointed as the Executive Chairman. His vast experience and visionary leadership have been instrumental in establishing Supriya Lifescience as a prominent name in the pharmaceutical industry. As Executive Chairman, Dr. Satish Wagh will continue to provide strategic direction and mentorship to the leadership team.

Upcoming E-conference

Other Related stories

Startup

Digitization